Table 1.
Baseline characteristics of the patients
|
N (%) or median (interquartile range) | ||||||
|---|---|---|---|---|---|---|
| Total n = 78 | TDF/FTC n = 61 | ABC/3TC n = 17 | EFV n = 36 | ATV/r n = 27 | LPV/r n = 15 | |
|
Sex: Male |
71 (91%) |
56 (91%) |
15 (88%) |
34 (94%) |
22 (81%) |
15 (100%) |
|
Age, years |
43 (34-47) |
44 (35-49) |
38 (32-43) |
42 (34-46) |
44 (35-48) |
42 (33-55) |
|
Body mass index |
23 (22-24) |
23 (22-25) |
22 (21-24) |
23 (22-25) |
22 (21-25) |
22 (21-24) |
|
Current smokers |
28 (36%) |
25 (41%) |
3 (18%) |
14 (39%) |
6 (22%) |
8 (53%) |
|
Viral hepatitis coinfection |
6 (8%) |
5 (8%) |
1 (6%) |
0 |
0 |
6 (40%) |
|
Prior AIDS |
7 (9%) |
5 (8%) |
2 (12%) |
2 (6%) |
1 (4%) |
4 (27%) |
|
CD4/mm
3
|
315 (217-409) |
304 (190-384) |
431 (330-512) |
342 (262-402) |
330 (263-446) |
177 (72-299) |
|
CD8/mm
3
|
959 (660-1345) |
949 (656-1335) |
1053 (762-1468) |
981 (774-1240) |
1111 (646-1506) |
709 (454-1109) |
|
CD4/CD8 ratio |
0.30 (0.19-0.46) |
0.28 (0.17-0.41) |
0.49 (0.22-0.59) |
0.33 (0.19-0.46) |
0.29 (0.24-0.49) |
0.16 (0.13-0.38) |
|
Viral load (log
10
copies/mL) |
4.6 (4.1-5.2) |
4.7 (4.3-5.2) |
4.4 (3.6-4.9) |
4.8 (4.3-5.2) |
4.4 (4-4.9) |
5.1 (4.6-5.3) |
| Viral load > 5 log 10 | 36% | |||||
TDF, tenofovir; FTC, emtricitabine; ABC, abacavir; 3TC, lamivudine; EFV, efavirenz; ATV/r, atazanavir/ritonavir; LPV/r, lopinavir/ritonavir.